confirmed HCC cases (ranging from 10 to 13), and further updates of the European cohort are still not available.
A recent study on the US industry-wide vinyl chloride cohort, with mortality updated through 2013, confirmed the association between cumulative exposure and mortality from both ASL and HCC. The diagnosis was based on the underlying cause reported in death certificates; no clinical or histological confirmation was available. The authors concluded that misdiagnosis of ASLs in death certificates especially in early years could have influenced findings on HCC.
Furthermore, no clear-cut trend in mortality from liver cirrhosis was reported, raising doubts about the association between VCM exposure and cirrhosis. 6 Published data from the US cohort, 6, 7 and from the polyvinyl chloride workers cohort in Taiwan, 8 suggest that mortality from liver cancer among VC workers, after peaking in the past decades, is decreasing in more recent follow-up periods. After the huge reduction in exposure achieved in the mid-1970s in the US and Western Europe, a decline in ASL and possibly in HCC risks might currently be observed. 6 The present study updates the follow-up of the Porto Marghera cohort, with additional clinical and histological information on the observed liver cancer deaths, with the following aims: 1) to confirm the role of VCM exposure in a large series of verified HCC cases; 2) to examine mortality from liver cirrhosis; and 3) to assess if mortality from liver cancer is decreasing after a follow-up of at least 30-40 years.
| METHODS
The cohort included 1658 workers employed in a VCM production and polymerization facility in Porto Marghera (northeastern Italy). Details about recruitment of the cohort, exposure assessment, and the early phases of the follow-up have been previously published. 4, 9 Briefly, all male subjects working in the plant in 1956 or hired thereafter until December 31, 1985 were recruited. A Job-Exposure Matrix (JEM) taking into account different job categories and changes in the production process and in the work environment over time was independently validated by external industrial hygienists. 3, 9 The JEM was then applied to individual work histories to compute the cumulative exposure in parts per million (ppm)-years to VCM. In the previous study, the mortality follow-up starting from January 1, 1973, was updated to July 31, 1999. The underlying cause of death retrieved from death certificates was coded according to the International Classification of Diseases, 9th Edition (ICD-9). 4 The present study updates the vital status until March 31, 2017.
The underlying cause of death of the deceased workers was retrieved from the regional mortality register, coded according to the ICD-9 up to 2007, and to the ICD-10 from 2007 onward. 10 The Standardized Mortality Ratios (SMR) with 95% confidence intervals (CI) were computed with regional age-and calendar period-specific rates as a reference. Overall mortality and 21 categories or causes of death were examined. Further analyses were carried out for liver cancer (ICD-9 155, ICD-10 C22), liver cirrhosis (ICD-9 571, ICD-10 K70, K73, K74), Lastly, the dose-response relationship between mortality from confirmed HCC and ASL and continuous cumulative VCM exposure was modeled through a penalized regression spline by specifying a Generalized Additive Model (GAM) for Poisson response. [11] [12] [13] We fixed a quite large number of knots (15) for the spline at the quantiles of the VCM exposure and the amount of smoothing was selected by minimizing the Generalized Cross Validation (GCV). We performed two separate analyses considering mortality from HCC alone and overall mortality from HCC and ASL together, adjusting for calendar period and age at risk. We obtained 95% confidence intervals for the doseresponse curve by a parametric bootstrap simulation with 10 000
replications. All analyses were performed using STATA 14 for the cohort mortality. The mgcv package of R software was used for GAM estimation. 14 
| RESULTS
Overall 731 deaths were observed as on March 31, 2017 (44% of cohort members); 12 workers (0.7%) could not be traced and were therefore censored at the end of the previous follow-up (July 1999).
The cause of death was retrieved for all except for three decedents.
The cohort accrued a total of 61 736 person-years at risk with a mean of 37.2 years follow-up for each worker (Table 1) .
Mortality from all causes, from circulatory and from respiratory diseases in the cohort was lower than the expected according to the regional reference rates ( According to estimated SMRs based on external reference rates, in the highest exposure category mortality from liver cirrhosis was increased, although without reaching statistical significance, mortality from liver cancer showed an eight-fold increase and that from liver cancer or cirrhosis combined a more than four-fold increase (Table 3) .
Mortality was significantly elevated after 20 years from the first exposure for liver cancer, and after 40 years for liver cirrhosis.
A confirmed diagnosis by clinical or histological charts was obtained Poisson regression analysis (Table 4) showed that mortality rates increased with cumulative VCM exposure for all the investigated outcomes. In particular, ASL cases were observed only among subjects with high VCM exposures; as a consequence, modified cut-points were adopted in order to distribute cases across categories of cumulative exposure. RRs above 5 and 2 were estimated for cumulative exposures greater than 2378 ppm-years for HCC and liver cirrhosis, respectively.
When flexible functions were used to model the relationship between VCM exposure and mortality, mortality rates for HCC appeared to increase already at levels below 2000 ppm-years ( Figure 1 ). The risk of HCC apparently leveled-off for exposures above 6000 ppm-years, a finding likely due to the competing risk of Table 4 ).
When HCC and ASL were grouped as the outcome variable, the risk continued to increase through the highest levels of cumulative exposure.
| DISCUSSION
The present study extends the mortality follow-up of a cohort of vinyl chloride workers, 4 with an increase in the overall number of observed deaths from 240 to 731, and of liver cancer deaths from 17 to 57. Such update allowed for further insights into the risk of neoplastic and nonneoplastic liver diseases among subjects with occupational exposure to VCM. We found that mortality from liver cancer was larger than the A study limit is that work histories were not updated with respect to the previous follow-up, being complete for all cohort members up to 1985, and to more recent study years only for 232 out of 585 subjects still employed in the plant in 1985. 4 However, the focus of the study was to examine the relationship between liver diseases and cumulative VCM exposure, which is a measure almost completely unaffected by the lack of more recent exposures. VCM exposure declined by two orders of magnitude, from about 500 ppm until the mid-1960s in many jobs (autoclave workers, dryers, maintenance workers), to about 1 ppm starting from the late 1970s. 9 Strengths of the study are the almost complete ascertainment of vital status and cause of death among cohort members; most importantly, histological and clinical confirmation of the diagnosis was retrieved for the majority of liver cancer deaths.
In fact, the assessment of vinyl chloride as a cause of HCC is complicated because most studies do not have histological or other definitive clinical information to discriminate HCC from ASL and/or secondary neoplasms. 2 After the first report of three cases of ASL in subjects employed in the manufacture of PVC resins, 15 epidemiological evidence for the carcinogenicity of vinyl chloride in humans mainly derives from two large multicenter cohort studies, one carried out in the US, 6, 7, 16, 17 and the other in Europe. 3, 18 In an internal analysis of the European cohort based on 10 verified cases of HCC, the risk significantly increased with cumulative VCM exposure. 3 An analysis of the Porto was an independent risk factor for both diseases. 5 Afterward, study from European sub-cohorts only provided figures on liver cancer mortality without differentiating histologic subtypes. 19 As regards the US cohort, only in the last report were data on 32 HCC cases provided; however, the diagnosis relied exclusively on information reported in death certificates. 6 Information on death certificates can be inaccurate as out of the 68 liver cancer deaths not registered as ASL in the US cohort, 32 were reported as HCC and the majority (36) as unspecified liver cancer. 6 The first study on the Taiwanese cohort of vinyl chloride workers retrieved clinical records of 18 out of 25 decedents from liver cancer. Of them, five had histological and five clinical confirmation of HCC, and no ASL was found. 20 However, no quantitative VCM exposure measure was available, and subsequent updates of the cohort did not analyze liver cancer subtypes. 8 The present study, therefore, is the largest investigation of the role of VCM exposure in the development of HCC with clinical/histopathological confirmation of the diagnosis:
notably out of 31 cases, in 25 diagnosis was based on histology, and in six on focal hepatic lesions coupled with high α-fetoprotein.
After the IARC re-assessment on the carcinogenicity of vinyl chloride, 1 some reviews were published claiming that the association between VCM exposure and HCC still remains unproven; the reviews were authored by consultants of the vinyl chloride industry. 21 The debate on the carcinogenicity of VCM can be regarded as a case study of data misrepresentation; 22 it is worth noting that in the last two decades the number of reviews downplaying the role of VCM issued by industry consultants has almost reached that of original studies reporting new data. 21 Such reviews are also used to protect the interests of the industry in the legal setting; the growing number of industry-funded publications allows subsequent reviews to report a predominance of articles reaching a certain conclusion. 21, 23 It must be remarked that stringent regulations for the vinyl chloride industry were introduced in western Europe and in the US in the late 1970s, but such achievements could not be met in other countries, where large plants with old-fashioned technologies continued to be in function with concentrations of VCM that remained at levels of former standards. 1 Furthermore, in western countries, the full knowledge of the long-term effects of VCM exposure is warranted in order to better shape health surveillance strategies for previously exposed workers. Within this context, the present study provides compelling evidence on the role of occupational exposure to VCM in HCC development.
A finding of the present study is the increased mortality from stomach cancer, confirming data from the previous update of the cohort. 4 However in the European cohort only a slight, non-significant increase in mortality was registered (87 deaths, SMR 1.12, CI 0.90-1.38), 3 and there is no a priori evidence on the association between VC exposure and stomach cancer. This underlines the importance of updating the whole European cohort, also with the aim of investigating cancer sites other than the liver.
As regards the risk of liver cirrhosis, the results reported in the literature are only apparently conflicting. SMR estimated in cohort studies for the whole study group of vinyl chloride workers are consistently close to the reference rates derived from the general population. This finding, already observed in the European and in the US cohorts, 3, 6 is confirmed in the present study, and represents the main reason advocated from industry consultants to criticize the association between liver cirrhosis and VCM exposure. By contrast, case-control studies or internal analyses carried out within cohorts, comparing workers with high versus low exposures, mainly confirm an exposureresponse association. 3, 5 The most common non-occupational etiologic factors for both liver cirrhosis and HCC are chronic viral hepatitis infection, alcohol consumption, and obesity/diabetes. The low overall and cardiovascular mortality observed in previous cohort studies as well as in the present report suggests a strong healthy worker hire effect involving some risk factors for liver diseases-at least obesity/diabetes, also strongly associated with cardiovascular risk. Moreover, liver cirrhosis and liver cancer do not represent independent outcomes: VCM exposure could both increase the risk of liver cirrhosis and accelerate the development of HCC in a cirrhotic liver, especially in subjects with high cumulative exposures. In fact, the presence of cirrhosis per se increases the risk of HCC independently from its etiology: the development of HCC is linked tightly to the evolution of cirrhosis through several mechanisms, including chromosomal instability. 24 Furthermore, vinyl chloride is mutagenic, causing in humans an increase in the frequency of chromosomal aberrations, micronucleus formation, sister chromatid exchange, Ki-ras and p53 gene mutations, 1 further increasing the risk of HCC development. The analysis of mortality data for two diseases representing subsequent steps in the same pathogenetic pathway appears tricky: when a liver cancer is diagnosed, the underlying liver cirrhosis can be omitted in the death certificate, or can be reported only as a contributory cause of death.
Consequently, routinely collected mortality data based on the underlying cause of death can be analyzed by grouping the two nosologic categories, as already performed in population studies carried out in the US 25 and in Italy. 26 In the present study, the SMR for liver cirrhosis and liver cancer combined was already highly increased in the 2379-5187 ppm-years exposure category (18 deaths observed, SMR = 3.22), where only two ASL cases were retrieved. An additional straightforward approach was to overcome the above intricacies through an internal analysis within the cohort, in order to remove the selection bias represented by the healthy worker hire effect. Furthermore, deaths from liver cirrhosis as the underlying cause were grouped with deaths from liver cancer only when cirrhosis was histologically or clinically evident. With this approach, a strong association between liver cirrhosis and cumulative VCM exposure was demonstrated.
In conclusion, the study confirms the role of VCM exposure in the largest available series of HCC cases with diagnosis based on histological/clinical evidence. Furthermore, the present findings support the association between VCM and liver cirrhosis, which can be masked in standard mortality studies by the healthy worker hire effect, and by the selection of liver cancer as the underlying cause of death.
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FIGURE 1 Dose-response relationship between primary liver cancer (hepatocellular carcinoma (HCC) alone, or HCC plus angiosarcoma) and cumulative exposure to vinyl chloride monomer (ppm-years) estimated through penalized spline generalized additive models: rate ratios (RR) with 95% confidence intervals (CI)
